Reversible posterior leukoencephalopathy syndrome: Report of three cases

Journal of Child Neurology

Volumn 20, Issue 12, 2005, Pages 990-993

  Ozyurek, Hamit ^a   Oguz, Gulben ^a   Ozen, Seza ^a   Akyuz, Canan ^a   Oguz, Kader Karli ^a   Anlar, Banu ^a   Aysun, Sabiha ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACTINOMYCIN; METHYLPREDNISOLONE; MIDAZOLAM; NIFEDIPINE; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; VINCRISTINE;

ADOLESCENT; CASE REPORT; CHEMOTHERAPY; CHILD HOSPITALIZATION; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DRUG BLOOD LEVEL; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GRAND MAL SEIZURE; HEADACHE; HUMAN; HYPERTENSION; HYPONATREMIA; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LEUKOENCEPHALOPATHY; MALE; MEDICAL LITERATURE; NEPHROBLASTOMA; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VOMITING;

ADOLESCENT; BRAIN DISEASES; CHILD, PRESCHOOL; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HEADACHE; HUMANS; KIDNEY NEOPLASMS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEIZURES; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; VISUAL PERCEPTION; WILMS TUMOR;

EID: 33644514629     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200121201     Document Type: Review

References (23)

1. Hinchey J, Chaves C, Appignani B, et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
2. Kwon S, Koo J, Lee S: Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361-364.
3. Laguna P, Martin T, Marchena MJ, Moya M: Posterior leukoencephalopathy reversible syndrome secondary to panarteritis nodosa. Med Clin (Barc) 1997;109:397-398.
4. Gimenez-Mesa E, Martinez-Salio A, Porta-Etessam J, et al: Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP. An Med Interna 2001;18:591-593.
5. Edwards MJ, Walker R, Vinnicombe S, et al: Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 2001;12:1327-1329
6. Ito Y, Niwa H, Iida, T, et al: Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997;49:1174-1175.
7. Mathy I, Gille M, van Raemdonck F, et al: Neurological complications of intravenous immunoglobulin (IVIg) therapy: An illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 1998;98:347-351
8. Delanty N, Vaughan C, Frucht S, Stubgen P: Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997;49:686-689.
9. Pavlakis SG, Frank Y, Chusid R: Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: Three names for an old syndrome. J Child Neurol 1999;14:277-281.
10. Antunes NL, Small TN, George D, et al: Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999;20:241-243.
11. Cooney MJ, Bradley WG, Symko SC, et al: Hypertensive encephalopathy: Complication in children treated for myeloproliferative disorders - Report of three cases. Radiology 2000;214:711-716.
12. Pavlakis SG, Frank Y, Kalina P, et al: Occipital-parietal encephalopathy: A new name for an old syndrome. Pediatr Neurol 1997;16:145-148.
13. Ay H, Buonanno FS, Schaefer PW, et al: Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI. Neurology 1998;51:1369-1376.
14. Schwartz RB, Jones KM, Kalina, P, et al: Hypertensive encephalopathy: Findings on CT, MR imaging and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379-383.
15. Pace MT, Slovis TL, Kelly JK , Abella SD: Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 1995;25:180-183.
16. Schwartz RB, Bravo SM, Klufas RA, et al: Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627-631.
17. Johansson BB: The blood brain barrier and cerebral blood flow in acute hypertension. Acta Med Scand (Suppl) 1983;678:107-112.
18. Schaefer PW, Buonanno FS, Gonzales RG, Schwamm LH: Diffusion-weighted imaging discriminated between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082-1085.
19. Sundt T: The cerebral autonomic nervous system: A proposed physiologic function and pathophysiologic response in subarachnoid hemorrhage and in focal cerebral ischemia. Mayo Clin Proc 1973;48:127-137.
20. Sommer BG, Henry ML, Ferguson RM: Cyclosporine-associated renal arteriopathy. Transplant Proc 1986;18:151-157.
21. Brown Z, Neild GH: Cyclosporine inhibits prostacyclin production by cultured human endothelial cells. Transplant Proc 1987;19:1178-1180.
22. Jarosz JM, Howlett DC, Cox TC, Bingham JB: Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 1997;39:711-715.
23. Eichler FS, Wang P, Wityk RJ, et al: Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002;23:833-837.